0001562180-23-000722.txt : 20230130 0001562180-23-000722.hdr.sgml : 20230130 20230130170207 ACCESSION NUMBER: 0001562180-23-000722 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230126 FILED AS OF DATE: 20230130 DATE AS OF CHANGE: 20230130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reine Allan CENTRAL INDEX KEY: 0001714023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39634 FILM NUMBER: 23568726 MAIL ADDRESS: STREET 1: C/O PIERIS PHARMACEUTICALS, INC. STREET 2: 255 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foghorn Therapeutics Inc. CENTRAL INDEX KEY: 0001822462 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-586-3100 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2023-01-26 false 0001822462 Foghorn Therapeutics Inc. FHTX 0001714023 Reine Allan 500 TECHNOLOGY SQUARE STE #700 CAMBRIDGE MA 02139 false true false false Chief Financial Officer Stock Option (right to buy) 8.38 2023-01-26 4 A false 90000.00 0.00 A 2033-01-25 Common Stock 90000.00 90000.00 D The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. /s /Adrian Gottschalk, Attorney-in-Fact for Allan Reine 2023-01-30